Adaptimmune Therapeutics Plc ADR (ADAPY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 06-2014 | 12-2013 | 06-2013 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 48,966 | 48,966 | 48,966 | N/A |
| Receivables | 0 | 2,687 | 2,687 | 2,687 | N/A |
| TOTAL | $0 | $51,653 | $51,653 | $51,653 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 0 | 1,366 | 1,366 | 1,366 | N/A |
| TOTAL | $0 | $1,366 | $1,366 | $1,366 | $N/A |
| Total Assets | $0 | $53,019 | $53,019 | $53,019 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 50,646 | 0 | 0 | 0 |
| TOTAL | $0 | $50,718 | $50,718 | $50,718 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $N/A | $N/A | $0 | $N/A |
| Total Liabilities | $0 | $50,718 | $50,718 | $50,718 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 0 | 3 | N/A | 0 | N/A |
| Retained earnings | 0 | -30,811 | -30,811 | -30,811 | N/A |
| Other shareholders' equity | 0 | 179 | 33,112 | 33,112 | 0 |
| TOTAL | $0 | $2,302 | $2,302 | $2,302 | $N/A |
| Total Liabilities And Equity | $0 | $53,019 | $53,019 | $53,019 | $0 |